X

Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NOT-AI-13-029: Notice of Clarification to PA-12-037 Research to Advance Vaccine Safety (R01)

Notice of Clarification to PA-12-037 "Research to Advance Vaccine Safety (R01)"


Notice Number: NOT-AI-13-029


Key Dates

Release Date:  February 27, 2013

Related Announcements

PA-12-037
NOT-AI-13-030

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The National Institute of Allergy and Infectious Diseases (NIAID) will not support clinical trials under PA-12-037 "Research to Advance Vaccine Safety (R01)" consistent with NIAID’s previously announced policy regarding Investigator-Initiated Clinical Trials (https://grants.nih.gov/grants/guide/notice-files/NOT-AI-05-021.html).

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Barbara Mulach, Ph.D.
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
Telephone: (240) 627-3322
Email: bmulach@niaid.nih.gov